AIT Austrian Institute of Technology GmbH-医療機器分野:企業M&A・提携分析

◆英語タイトル:AIT Austrian Institute of Technology GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011292
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AIT Austrian Institute of Technology GmbH (AIT) is a research and technology institute that provides research development services in various fields. The institute offers research on health and environment, energy, mobility, digital safety and security, and innovation systems. Its health and environment research services include biomedical and bio molecular solutions, biological resources database, microbial detection and water treatment, among others. It offers services for the preparation of smart grids, photovoltaics, thermal energy systems, smart cities and develops business models in mobility, and digital safety and security. The institute also offers research services in the areas of innovation systems modeling, studies and foresight from various segments. It operates in Vienna, Wiener Neustadt, Braunau am Inn, Graz, Hall in Tirol and Tulln, Austria. AIT is headquartered in Vienna, Austria.

AIT Austrian Institute of Technology GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
AIT Austrian Institute of Technology GmbH, Medical Equipment Deals By Type, 2011 to YTD 2017 6
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deal Details 10
Partnerships 10
Blue Earth Diagnostics and Seibersdorf Lab Enters into Distribution Agreement 10
Nanyang Technological University Enters into Research Agreement with Austrian Institute of Technology and Medical University of Vienna 11
Caprion Biosciences, Asuragen and AIT Austrian Institute of Technology Enter into Agreement with Cancer Research and Abcodia 12
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 14
RiboMed Enters Into Development Agreement With Austrian Institute Of Technology For Lung Cancer Assay 15
Abcodia Partners with AIT Austrian Institute of Technology 16
AIT Austrian Institute of Technology GmbH – Key Competitors 17
AIT Austrian Institute of Technology GmbH – Key Employees 18
AIT Austrian Institute of Technology GmbH – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
AIT Austrian Institute of Technology GmbH, Medical Equipment, Key Facts 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
AIT Austrian Institute of Technology GmbH, Medical Equipment Deals By Type, 2011 to YTD 2017 6
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
AIT Austrian Institute of Technology GmbH, Deals By Market, 2011 to YTD 2017 8
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Blue Earth Diagnostics and Seibersdorf Lab Enters into Distribution Agreement 10
Nanyang Technological University Enters into Research Agreement with Austrian Institute of Technology and Medical University of Vienna 11
Caprion Biosciences, Asuragen and AIT Austrian Institute of Technology Enter into Agreement with Cancer Research and Abcodia 12
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 14
RiboMed Enters Into Development Agreement With Austrian Institute Of Technology For Lung Cancer Assay 15
Abcodia Partners with AIT Austrian Institute of Technology 16
AIT Austrian Institute of Technology GmbH, Key Competitors 17
AIT Austrian Institute of Technology GmbH, Key Employees 18
AIT Austrian Institute of Technology GmbH, Other Locations 20
AIT Austrian Institute of Technology GmbH, Subsidiaries 20

★海外企業調査レポート[AIT Austrian Institute of Technology GmbH-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avery Dennison Corporation (AVY):医療機器:M&Aディール及び事業提携情報
    Summary Avery Dennison Corporation (Avery Dennison) is a labeling and packaging materials and solutions provider. The company produces pressure-sensitive materials, tags, labels, tickets, and other converted products. It also manufactures and sells fasteners, tickets, tags, RFID inlays and tags, and …
  • GateHouse Media, Inc.:企業のM&A・事業提携・投資動向
    GateHouse Media, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's GateHouse Media, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Cancer Genetics Inc (CGIX):企業の財務・戦略的SWOT分析
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that offers diagnostic products and services enabling precision medicine in the field of oncology. It offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. The company's oncology tests and laboratory ser …
  • DiaGenic ASA (NEL)-製薬・医療分野:企業M&A・提携分析
    Summary DiaGenic ASA (DiaGenic) is a medical device company that develops innovative in vitro diagnostic products for early detection of diseases. The company specializes in developing blood-based biomarkers. Its ADtect product is a blood test that helps distinguish mild to moderate range AD from th …
  • Nectar Lifesciences Ltd (NECLIFE):企業の財務・戦略的SWOT分析
    Summary Nectar Lifesciences Ltd (NecLife) is a research driven pharmaceutical company that manufactures active pharmaceutical ingredients (APIs). The company provides contract research and manufacturing services such as process development and optimization, process scale up and validation, multi kil …
  • Gannett Co., Inc.:戦略・SWOT・企業財務分析
    Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • BelAZ:企業の戦略・SWOT・財務情報
    BelAZ - Strategy, SWOT and Corporate Finance Report Summary BelAZ - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Saudi Basic Industries Corp (2010):企業の財務・戦略的SWOT分析
    Saudi Basic Industries Corp (2010) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Singulex Inc:医療機器:M&Aディール及び事業提携情報
    Summary Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and p …
  • Almirall S.A.:企業の戦略・SWOT・財務分析
    Almirall S.A. - Strategy, SWOT and Corporate Finance Report Summary Almirall S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Bionure Farma SL-製薬・医療分野:企業M&A・提携分析
    Summary Bionure Farma SL (Bionure) is a healthcare service provider that provides treatment for ophthalmological diseases, with concentration on multiple sclerosis and glaucoma. The company concentrates on two conditions of vision impairment which include optic neuritis and neuromyelitis optica. Its …
  • Minoryx Therapeutics sl-製薬・医療分野:企業M&A・提携分析
    Summary Minoryx Therapeutics sl (Minoryx) is a clinical stage biotechnology company that develops treatments for life threatening rare diseases. The company provides discovery, preclinical research, development and clinical trial programs. It develops ALD-MIN, morquio B and PCT drugs used for lysoso …
  • BDO Unibank Inc:企業の戦略・SWOT・財務情報
    BDO Unibank Inc - Strategy, SWOT and Corporate Finance Report Summary BDO Unibank Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • NeuroDerm Ltd:医療機器:M&Aディール及び事業提携情報
    Summary NeuroDerm Ltd (NeuroDerm), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a pharmaceutical company that develops of drugs for the treatment of Parkinson’s disease and central nervous system (CNS) disorders through proprietary reformulations of its existing drugs. The company’s liquid form …
  • China Galaxy Securities Co., Ltd. (6881):企業の財務・戦略的SWOT分析
    China Galaxy Securities Co., Ltd. (6881) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Molex LLC:企業のM&A・事業提携・投資動向
    Molex LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Molex LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Personal Genome Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Personal Genome Diagnostics Inc (PGD) is a genomic solution provider. The company develops next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides a portfolio of regulated tissue-based and liquid biopsy genomic products for laborat …
  • Continental AG (CON):企業の財務・戦略的SWOT分析
    Continental AG (CON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • O’Learys Trademark AB:企業の戦略・SWOT・財務分析
    O'Learys Trademark AB - Strategy, SWOT and Corporate Finance Report Summary O'Learys Trademark AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Kforce Inc. (KFRC):企業の財務・戦略的SWOT分析
    Kforce Inc. (KFRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆